qfx

Eli Lilly, to its credit, was quick off the mark with Mounjaro and Zepbound, which have proven remarkably effective at… well, reducing appetite. They now account for a rather alarming 56% of the company’s revenue. Which is, statistically speaking, a lot. (Imagine building an entire financial empire on the premise that people want to eat less. It’s a bold strategy, Cotton, let’s see if it pays off.) The market, however, seems to believe this is not merely a temporary trend, but a permanent reshaping of the human condition. Hence the rather enthusiastic price-to-earnings ratio of 44 and a dividend yield that wouldn’t trouble a particularly frugal ant. It’s priced for perfection, which, as any seasoned trader knows, is a dangerous place to be. (Perfection, much like a perfectly brewed cup of tea, is an elusive and ultimately unattainable goal. Striving for it only leads to disappointment and lukewarm beverages.)

Yet, the market, that fickle mistress, has recently exhibited a touch of the vapors regarding Meta’s expenditures. Investors, it appears, are beginning to suspect that throwing vast sums at innovation doesn’t necessarily guarantee a proportionate return. A rather novel concept, though one suspects the truly astute have always known it. The worry, as it were, is that the potential revenue from this digital alchemy may not quite match the expense of the ingredients.

AWS demonstrated robust growth in the fourth quarter of 2025, reporting a 24% year-over-year revenue increase. While Amazon possesses internal hardware design capabilities, the complexity and capital intensity of developing a complete AI hardware ecosystem necessitate reliance on external providers. Nvidia currently occupies a dominant position in this landscape.

The S&P 500 is hitting highs, sure. But that doesn’t mean this AI stuff is any different. It just means people are easily distracted. They see a shiny new toy and suddenly forget all the basic principles of investing. It’s like they’ve never seen a pump-and-dump before. Honestly, it’s insulting.

To speak of Taiwan Semiconductor Manufacturing (TSM 4.23%) is to speak of a near-total dominion. It is a position achieved not through superior vision, but through the relentless, unforgiving demands of a process – the fabrication of logic chips – that few others possess the capital, the expertise, or, frankly, the will to master. The shrinking of nodes, the pursuit of density… these are not merely technical challenges, but acts of attrition, slowly eliminating competitors, concentrating power into fewer and fewer hands. The foundries, those vast, humming cathedrals of silicon, require near-constant utilization to justify their existence – a precarious balance, demanding a constant flow of orders, a dependence that TSMC has skillfully cultivated.